Noriva Therapeutics develops novel therapies for patients with devastating disease and no approved treatment — built on clinical evidence, driven by human urgency.
"Some patients suffer in ways medicine has no answer for.
Noriva was founded by a physician who refused to accept that."
Noriva Therapeutics was born at the bedside — from a physician's firsthand witness of suffering in patients with devastating disease and no path forward. Moved by the depth of that suffering, our founder pursued years of rigorous clinical investigation, developing an innovative therapeutic approach grounded in evidence and driven by compassion. That founding conviction shapes everything we build.
Noriva develops therapeutic platforms for rare diseases where no approved options exist — pursuing regulatory clarity and meaningful outcomes for the patients who need it most.
For partnership, regulatory, business development, or clinical inquiries